The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia
- 1 July 2007
- journal article
- Published by American Society of Hematology in Blood
- Vol. 110 (1) , 9-17
- https://doi.org/10.1182/blood-2006-12-022038
Abstract
After allogeneic blood or bone marrow transplantation, donor T cells interact with a distorted antigen-presenting cell (APC) environment in which some, but not all, host APCs are replaced by APCs from the donor. Significantly, host APCs are required for the priming of acute graft-versus-host disease (GVHD). Donor APCs play a lesser role in the induction of acute GVHD despite their predicted capacity to cross-present host antigens. In contrast, donor APCs may play a role in perpetuating the tissue injury observed in chronic GVHD. Host APCs are also required for maximal graft-versus-leukemia responses. Recent studies have suggested potential strategies by which the continued presence of host APCs can be exploited to prime strong donor immunity to tumors without the induction of GVHD.Keywords
This publication has 134 references indexed in Scilit:
- Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouseBlood, 2007
- Identification of a radio-resistant and cycling dermal dendritic cell population in mice and menThe Journal of Experimental Medicine, 2006
- Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activityBlood, 2006
- Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusionsBlood, 2006
- An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissuesThe Journal of Experimental Medicine, 2006
- The Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In VivoAmerican Journal of Transplantation, 2005
- Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cellsBlood, 2005
- In vivo imaging of graft-versus-host-disease in miceBlood, 2004
- Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantationBlood, 2003
- Preterminal host dendritic cells in irradiated mice prime CD8+ T cell–mediated acute graft-versus-host diseaseJournal of Clinical Investigation, 2002